Skip to content
healthcare.dev

Methylphenidate Hydrochloride

NDC 0527-3313, Methylphenidate Hydrochloride, tablet, extended release, from Lannett Company, Inc..

Product NDC
0527-3313
Status
Listed
Labeler
Lannett Company, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211918
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0527-3313 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHYLPHENIDATE HYDROCHLORIDE54 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
0527-3313-3700527331337100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-3313-37)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/44737c1d-fe75-409e-8a58-591696d3d7aa

Use it

Look up 0527-3313 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0527-3313 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0527-3313. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.